Page title
Emerging Practices

Main page content
SAMHSA is committed to improving prevention, treatment, and recovery support services for mental and substance use disorders.

FDA Clears Mobile Medical App to Help Those with Opioid Use Disorder Stay in Recovery Programs, December 10, 2018

Today, the U.S. Food and Drug Administration cleared a mobile medical application (app) to help increase retention (the amount of time a patient participates) in an outpatient treatment program for individuals with opioid use disorder (OUD). The reSET-O app is a prescription cognitive behavioral therapy intended to be used in addition to outpatient treatment under the care of a health care professional, in conjunction with treatment that includes buprenorphine and contingency management.

Read the full Press Release.

Last Updated

Last Updated: